ImmunOs Therapeutics

Schlieren, Switzerland

ImmunOs Therapeutics is a clinical-stage biotechnology company.

$11.0M raised

Sep 2024

Series C

Biotechnology Health Care Pharmaceutical

Top Investors

Lightspeed Venture PartnersSamsara BioCapitalredalpineMission BioCapitalEuropean Union

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about ImmunOs Therapeutics

How much funding has ImmunOs Therapeutics raised?

ImmunOs Therapeutics has raised $11.0M in total funding. The most recent round was Series C. The last funding was announced in September 2024.

Who are ImmunOs Therapeutics's investors?

ImmunOs Therapeutics's investors include Lightspeed Venture Partners, Samsara BioCapital, redalpine, Mission BioCapital, European Union.

Where is ImmunOs Therapeutics headquartered?

ImmunOs Therapeutics is headquartered in Schlieren, Switzerland.

What does ImmunOs Therapeutics do?

ImmunOs Therapeutics is a clinical-stage biotechnology company.

What stage is ImmunOs Therapeutics at?

ImmunOs Therapeutics is at the Series C stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 17, 2024.

MLA

"ImmunOs Therapeutics — Funding & Investors." VCBacked, September 17, 2024, https://www.vcbacked.co/company/immunos-therapeutics. Accessed June 4, 2026.

APA

VCBacked. (2024). ImmunOs Therapeutics — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/immunos-therapeutics

Wikipedia (cite web)

{{cite web |title=ImmunOs Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/immunos-therapeutics |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 17, 2024.